Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06201988 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Revealing Engagement Patterns Among Hepatic Encephalopathy Patients

StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 12, 2024 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Jan 2025 to Jan 2026 Start date: Jan 2024 to Jan 2025 · Completion date: Jan 2026 to Jan 2027v2 Show 2 more changesShow less
    • Start date: Jan 2024 to Jan 2025
    • Completion date: Jan 2026 to Jan 2027
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to investigate the influences behind patient choices regarding involvement, discontinuation, or re-engagement in hepatic encephalopathy clinical trials. Uncovering these factors is essential to enhance the relevance and efficacy of future research endeavors. In essence, this trial aims to deepen understanding of the factors influencing participation in hepatic encephalopathy clinical trials. Elevating participation rates could expedite the development of innovative treatments for this challenging condition.
Trial Details
NCT Number NCT06201988
Lead Sponsor Power Life Sciences Inc.
Conditions Hepatic Encephalopathy
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov